Original article Infliximab efficacy in rheumatoid arthritis after an inadequate response to etanercept or adalimumab: results of a target-driven active switch study

2014

Objective: Evaluate efficacy of infliximab with response-driven dosing in patients with active RA.

Keywords:

References

Citations